Glycogen phosphorylase inhibitors as potential drugs for the treatment of type 2 diabetes

被引：0
|
作者：
Ganotidisi, Minas H. [1 ]
Elemes, Yiannis [1 ]
Alexopoulos, Charalampos [1 ]
Sakarellos, Constantinos [1 ]
Kosmopoulou, Magda N. [1 ]
Chrysina, Evangelia D. [1 ]
Leonidas, Demetres D. [1 ]
Oikonomakos, Nikos G. [1 ]
机构：
[1] Univ Ioannina, Dept Chem, GR-45110 Ioannina, Greece
来源：
Peptides 2004, Proceedings: BRIDGES BETWEEN DISCIPLINES | 2005年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：844 / 845
页数：2
相关论文
共 50 条
  • [1] GLYCOGEN PHOSPHORYLASE INHIBITORS AS POTENTIAL DRUGS FOR THE TREATMENT OF TYPE 2 DIABETES
    Ganotidis, M.
    Elemes, Y.
    Alexopoulos, C. H.
    Sakarellos, C.
    Kosmopoulou, M.
    Chrysina, E.
    Leonidas, D.
    Oikonomakos, N.
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 244 - 244
  • [2] Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus
    Treadway, JL
    Mendys, P
    Hoover, DJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (03) : 439 - 454
  • [3] Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes
    Joseph M. Hayes
    Anastassia L. Kantsadi
    Demetres D. Leonidas
    Phytochemistry Reviews, 2014, 13 : 471 - 498
  • [4] Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes
    Hayes, Joseph M.
    Kantsadi, Anastassia L.
    Leonidas, Demetres D.
    PHYTOCHEMISTRY REVIEWS, 2014, 13 (02) : 471 - 498
  • [5] Pentacyclic triterpenes, inhibitors of glycogen phosphorylase, as potential drugs for type 2 diabetes: X-ray crystallographic studies
    Zographos, S. E.
    Leonidas, D. D.
    Alexacou, K. M.
    Gimisis, T.
    Hayes, J. M.
    Oikonomakos, N. G.
    Wen, X.
    Sun, H.
    Liu, J.
    Cheng, K.
    Zhang, P.
    Zhang, L.
    Hao, J.
    Zhang, L.
    Ni, P.
    PLANTA MEDICA, 2008, 74 (09) : 1146 - 1147
  • [6] Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes
    Klabunde, T
    Wendt, KU
    Kadereit, D
    Brachvogel, V
    Burger, HJ
    Herling, AW
    Oikonomakos, NG
    Kosmopoulou, MN
    Schmoll, D
    Sarubbi, E
    von Roedern, E
    Schönafinger, K
    Defossa, E
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) : 6178 - 6193
  • [7] GLUCOSE ANALOG INHIBITORS OF GLYCOGEN-PHOSPHORYLASE - THE DESIGN OF POTENTIAL-DRUGS FOR DIABETES
    MARTIN, JL
    VELURAJA, K
    ROSS, K
    JOHNSON, LN
    FLEET, GWJ
    RAMSDEN, NG
    BRUCE, I
    ORCHARD, MG
    OIKONOMAKOS, NG
    PAPAGEORGIOU, AC
    LEONIDAS, DD
    TSITOURA, HS
    BIOCHEMISTRY, 1991, 30 (42) : 10101 - 10116
  • [8] Glycogen phosphorylase inhibitors in the regulation of carbohydrate metabolism in type 2 diabetes
    A. A. Spasov
    N. I. Chepljaeva
    E. S. Vorob’ev
    Russian Journal of Bioorganic Chemistry, 2016, 42 : 133 - 142
  • [9] Glycogen phosphorylase inhibitors in the regulation of carbohydrate metabolism in type 2 diabetes
    Spasov, A. A.
    Chepljaeva, N. I.
    Vorob'ev, E. S.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2016, 42 (02) : 133 - 142
  • [10] Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes
    Stravodimos, George A.
    Chetter, Ben A.
    Kyriakis, Efthimios
    Kantsadi, Anastassia L.
    Chatzileontiadou, Demetra S. M.
    Skamnaki, Vassiliki T.
    Kato, Atsushi
    Hayes, Joseph M.
    Leonidas, Demetres D.
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (04) : 384 - 403
12345